Co-Activation of Metabotropic Glutamate Receptor 3 and Beta-Adrenergic Receptors Modulates Cyclic-AMP and Long-Term Potentiation, and Disrupts Memory Reconsolidation
Author:
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Pharmacology
Link
http://www.nature.com/articles/npp2017136.pdf
Reference51 articles.
1. Battaglia G, Bruno V, Ngomba RT, Di Grezia R, Copani A, Nicoletti F (1998). Selective activation of group-II metabotropic glutamate receptors is protective against excitotoxic neuronal death. Eur J Pharmacol 356: 271–274.
2. Battaglia G, Molinaro G, Riozzi B, Storto M, Busceti CL, Spinsanti P et al (2009). Activation of mGlu3 receptors stimulates the production of GDNF in striatal neurons. PLoS ONE 4: e6591.
3. Bradley SJ, Challiss RA (2012). G protein-coupled receptor signalling in astrocytes in health and disease: a focus on metabotropic glutamate receptors. Biochem Pharmacol 84: 249–259.
4. Bruno V, Battaglia G, Casabona G, Copani A, Caciagli F, Nicoletti F (1998). Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-beta. J Neurosci 18: 9594–9600.
5. Bruno V, Battaglia G, Copani A, Giffard RG, Raciti G, Raffaele R et al (1995). Activation of class II or III metabotropic glutamate receptors protects cultured cortical neurons against excitotoxic degeneration. Eur J Neurosci 7: 1906–1913.
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Single cell molecular alterations reveal target cells and pathways of conditioned fear memory;Brain Research;2023-05
2. Comparative assessment of the effects of DREADDs and endogenously expressed GPCRs in hippocampal astrocytes on synaptic activity and memory;Frontiers in Cellular Neuroscience;2023-03-27
3. Metabotropic glutamate receptor 3 as a potential therapeutic target for psychiatric and neurological disorders;Pharmacology Biochemistry and Behavior;2022-11
4. Advances in translating mGlu2 and mGlu3 receptor selective allosteric modulators as breakthrough treatments for affective disorders and alcohol use disorder;Pharmacology Biochemistry and Behavior;2022-09
5. Progress and Pitfalls in Developing Agents to Treat Neurocognitive Deficits Associated with Schizophrenia;CNS Drugs;2022-07-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3